These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26756617)

  • 1. Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.
    Sun L; Dong S; Dong C; Sun K; Meng W; Lv P; Yin H; Ming L; He F
    Cancer Biomark; 2016; 16(2):265-73. PubMed ID: 26756617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.
    Dong S; Yin H; Dong C; Sun K; Lv P; Meng W; Ming L; He F
    Dis Markers; 2016; 2016():1857067. PubMed ID: 26989293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
    Li SP; Su HX; Zhao D; Guan QL
    Med Sci Monit; 2016 Jun; 22():2195-201. PubMed ID: 27345473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
    Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
    He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
    World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
    Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
    PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
    Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
    Cui Y; Xue Y; Dong S; Zhang P
    J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
    Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
    Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21.
    Rong H; Chen B; Ma K; Wei X; Peng J; Zhu J
    Cancer Biother Radiopharm; 2021 Apr; 36(3):273-279. PubMed ID: 32401035
    [No Abstract]   [Full Text] [Related]  

  • 11. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
    Chen J; Chen M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1048-1053. PubMed ID: 30523223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
    Sun J; Song K; Feng X; Gao S
    Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
    Li J; Li M; Gao F; Ge X
    Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
    Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
    Wang C; Guan S; Liu F; Chen X; Han L; Wang D; Nesa EU; Wang X; Bao C; Wang N; Cheng Y
    Br J Cancer; 2016 Feb; 114(3):290-7. PubMed ID: 26794279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
    Bai Y; Lin H; Fang Z; Luo Q; Fang Y; Su Y; Hu Q; Duan H; Chen F; Zhang ZY
    Biomark Med; 2017 May; 11(5):431-441. PubMed ID: 28621611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
    Komatsu S; Ichikawa D; Takeshita H; Tsujiura M; Morimura R; Nagata H; Kosuga T; Iitaka D; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
    Br J Cancer; 2011 Jun; 105(1):104-11. PubMed ID: 21673684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.